accelerator investment venture capital 
500
OCTOBER 25, 2019
How has corporate venture capital changed? Conventional wisdom dictated that incumbents should focus their innovation efforts on R&D and growing their cash cows while investing in a few startups. But the rate of change has accelerated and with it, the balance of internal versus external investment.
Both Sides of the Table
APRIL 27, 2014
I was having dinner with a friend last night and we were chatting about venture capital and a bit about what I’ve learned. I started in 2007 with a thesis that my primary investment decision would be about the team (70%) and only afterward about the market opportunity (30%).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
500
DECEMBER 20, 2019
It’s been a crazy journey for us from a small first batch of startups in our Silicon Valley Accelerator to running accelerators across the globe and investing in founders from over 76 countries. Over the past nine years, the venture capital landscape has dramatically changed.
500
MARCH 26, 2020
When I moved to San Francisco in 2012, I was working on my fourth startup and looking to join an accelerator. 500 immediately stood out to me, not only for their reputation as one of the top accelerators in Silicon Valley, but also because they seemed to be one of the few VCs at the time that recognized that true entrepreneurship was blind.
Both Sides of the Table
JUNE 8, 2014
Cincinnati, like many startup communities in the US over the past 5 years, has revitalized important regions in its urban core, created accelerators, built co-working facilities, pooled together angel capital, attracted VCs, involved educational institutions and solicited the help of important corporations in a more cohesive ecosystem.
Revolution
OCTOBER 31, 2024
Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the Drug Development Process The oversubscribed $62M Series C will be used to expand the team, accelerate platform development, and advance its clinical-stage pipeline of precision oncology therapeutics.
500
JUNE 9, 2020
From taking all aspects of our accelerators digital (including our Demo Day) to rethinking the opportunities of the future, we’ve taken this moment to analyze what innovations can come from this time and new opportunities that arise from our changing environment. As a VC firm, we’ve had to adapt many aspects of our business as well.
Expert insights. Personalized for you.
204 
Let's personalize your content